首页> 外文期刊>Clinica chimica acta: International journal of clinical chemistry and applied molecular biology >Effect of iron deficiency anemia and iron supplementation on HbA1c levels - Implications for diagnosis of prediabetes and diabetes mellitus in Asian Indians
【24h】

Effect of iron deficiency anemia and iron supplementation on HbA1c levels - Implications for diagnosis of prediabetes and diabetes mellitus in Asian Indians

机译:缺铁性贫血和铁对HBA1C水平的影响 - 对亚洲印第安人诊断前脂肪酸和糖尿病的影响

获取原文
获取原文并翻译 | 示例
           

摘要

Abstract Background We investigated the effect of iron deficiency anemia (IDA) on levels of glycated hemoglobin (HbA1c) and to compare its levels before and after iron supplementations. Methods Age and sex matched subjects were enrolled and clustered in 2 groups: IDA ( n = 62) and healthy controls (HC; n = 60). HbA1c levels were estimated by HPLC. Hemogram were estimated by hematology analyser. Serum ferritin (ELISA) and other parameters of iron profile were measured by standard guidelines of ICSH. HbA1c values and iron studies were repeated after 3 months of iron supplementation to determine the effect of iron therapy on HbA1c levels. Results Significantly higher HbA1c levels were observed in IDA subjects compared to HC (5.51 ± 0.696 v/s 4.85 ± 0.461%, p 0.001). A significant negative correlation was observed between HbA1c and hemoglobin, hematocrit, RBC count, MCH, MCHC and serum ferritin in IDA subjects ( r = ? 0.632, ? 0.652, ? 0.384, ? 0.236, ? 0.192 and ? 0.441). Significant decline was noticed in HbA1c levels in IDA subjects after iron supplementation (5.51 ± 0.696 before treatment v/s 5.044 ± 0.603 post-treatment; p 0.001). Post treatment, 70% subjects (14/20) with HbA1c in pre-diabetes range normalised to normal glucose tolerance (NGT) range and out of 6 patients with pre-treatment HbA1c in diabetes range, 5 reverted to pre-diabetes range while 1 of them reverted to the NGT range. Conclusions Caution must be exercised in interpreting the results of HbA1c in patients of IDA and iron deficiency must be corrected before diagnosing diabetes and pre-diabetes solely on the basis of HbA1c criteria. Highlights ? Recently HbA1c has been recommended as a sole diagnostic criterion for prediabetes & diabetes mellitus. ? Iron deficiency anemia (IDA) was associated with a significant increase in baseline HbA1c measured by HPLC. ? Iron supplementation significantly decreases HbA1c levels. ? Iron deficiency must be corrected before any diagnostic decision is made solely on the basis of HbA1c in areas with a high prevalence of IDA.
机译:摘要背景我们研究了缺铁性贫血(IDA)对糖化血红蛋白(HBA1C)水平的影响,并比较铁补充剂前后的水平。方法中期和性匹配受试者在2组中注册并聚集在2组:IDA(n = 62)和健康对照(HC; n = 60)中。 HPLC估算HBA1C水平。血液学分析仪估算了六视图。通过ICSH的标准指南测量血清铁蛋白(ELISA)和铁型材的其他参数。在3个月的铁补充后重复HBA1C值和铁研究,以确定铁治疗对HBA1C水平的影响。结果与HC相比,在IDA受试者中观察到较高的HBA1C水平(5.51±0.696 V / s 4.85±0.461%,P <0.001)。在IDA受试者中,HBA1C和血红蛋白,血细胞比容,RBC计数,MCH,MCHC和血清铁蛋白之间观察到显着的负相关(R = 0.632,α0.652,β0.384,?0.236,?0.192和?0.441)。在铁补充剂后IDA受试者的HBA1C水平中注意到显着下降(治疗前5.044±0.696 5.044±0.603后处理; P <0.001)。治疗后,70%受试者(14/20)在糖尿病前糖尿病前的HBA1C标准化为正常葡萄糖耐量(NGT)范围内,其中6例患有糖尿病的预处理患者的患者,5患者恢复到糖尿病前范围内1它们恢复到NGT范围。结论在解释IDA患者的解释中必须谨慎行事,并且在仅在HBA1C标准的基础上诊断糖尿病和糖尿病前糖尿病前必须纠正铁缺乏症。强调 ?最近,HBA1C已被推荐为Prediapetes&amp的唯一诊断标准;糖尿病糖尿病。还缺铁性贫血(IDA)与HPLC测量的基线HBA1C的显着增加有关。还铁补充显着降低了HBA1C水平。还在任何诊断决策中,必须纠正铁缺乏症,以在ida患病率高的地区的HBA1C的基础上进行。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号